ОНКОНАЗЕ-ПЕГ/ ONCONASE-PEG

Опис товару

About ОНКОНАЗЕ-ПЕГ/ ONCONASE-PEG

ОНКОНАЗЕ-ПЕГ/ ONCONASE-PEG is a medication used in the treatment of acute lymphoblastic leukemia (ALL) in patients who have developed or are at high risk of developing anthracycline-induced cardiotoxicity. It belongs to a class of drugs known as asparaginase enzymes.

Key Benefits & Uses

• Treatment of acute lymphoblastic leukemia (ALL) in patients with anthracycline-induced cardiotoxicity
• Used in patients who have developed or are at high risk of developing anthracycline-induced cardiotoxicity
• Part of a chemotherapy regimen to treat ALL

Active Ingredient & Action

ОНКОНАЗЕ-ПЕГ/ ONCONASE-PEG contains the active ingredient Pegaspargase, a recombinant form of asparaginase enzyme. Pegaspargase works by depleting the amino acid asparagine, which is essential for the growth and survival of lymphoblasts. By depleting asparagine, Pegaspargase inhibits the growth of lymphoblasts, ultimately leading to the reduction of leukemia cells.

Important Notes

ОНКОНАЗЕ-ПЕГ/ ONCONASE-PEG should only be used under the guidance of a qualified healthcare professional. Patients should be closely monitored for signs of pancreatitis, allergic reactions, and thrombosis. It is essential to follow the recommended dosage and administration schedule to minimize the risk of adverse effects.